174 related articles for article (PubMed ID: 8499625)
21. [Platelet autoantibody and its impact on platelet in patients with idiopathic thrombocytopenic purpura].
Zhou J; Liao J; Jiang NG; Kuang LH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):977-9. PubMed ID: 18095600
[TBL] [Abstract][Full Text] [Related]
22. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
23. Novel approaches to refractory immune thrombocytopenic purpura.
Bussel JB
Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
[TBL] [Abstract][Full Text] [Related]
24. Alternate considerations for current concepts in ITP.
Thachil J
Hematology; 2014 Apr; 19(3):163-8. PubMed ID: 23683944
[TBL] [Abstract][Full Text] [Related]
25. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
26. [Immune thrombocytopenic purpura (ITP)].
Udvardy M
Orv Hetil; 2001 Dec; 142(49):2723-30. PubMed ID: 11883173
[TBL] [Abstract][Full Text] [Related]
27. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.
Rossi G; Cattaneo C; Motta M; Pizzocaro C; Lanzi S; Pouchè A
Hematol J; 2002; 3(3):148-52. PubMed ID: 12111651
[TBL] [Abstract][Full Text] [Related]
28. [Pathogenic relevance of platelet-associated autoantibodies in chronic ITP--studies before and after splenectomy in three patients with chronic ITP by direct immunoprecipitation procedure].
Tomiyama Y; Take H; Kosugi S; Kashiwagi H; Kanayama Y; Kurata Y; Matsuzawa Y
Rinsho Ketsueki; 1993 Jan; 34(1):21-7. PubMed ID: 8450603
[TBL] [Abstract][Full Text] [Related]
29. [Danazol - effective second line therapy in idiopathic thrombocytopenic purpura in children. Three case reports].
Szmydki-Baran A; Adamowicz-Salach A; Gołebiowska-Staroszczyk S
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1130-4. PubMed ID: 19531838
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.
Yang R; Han ZC
Int J Hematol; 2000 Jan; 71(1):18-24. PubMed ID: 10729989
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
[TBL] [Abstract][Full Text] [Related]
32. Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.
Andrès E; Zimmer J; Noel E; Kaltenbach G; Koumarianou A; Maloisel F
Drugs Aging; 2003; 20(11):841-6. PubMed ID: 12964890
[TBL] [Abstract][Full Text] [Related]
33. [Idiopathic thrombocytopenic purpura: therapeutic aspects in the adult].
Canevari A; Pagnucco G; Castelli G; Livraghi A; Santagostino A; Bernasconi C
Haematologica; 1991 Jun; 76 Suppl 3():124-30. PubMed ID: 1752509
[No Abstract] [Full Text] [Related]
34. Effects of kami-kihi-to (jia-wei-gui-pi-tang) on autoantibodies in patients with chronic immune thrombocytopenic purpura.
Yamaguchi K; Kido H; Kawakatsu T; Fukuroi T; Suzuki M; Yanabu M; Nomura S; Kokawa T; Yasunaga K
Am J Chin Med; 1993; 21(3-4):251-5. PubMed ID: 8135169
[TBL] [Abstract][Full Text] [Related]
35. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic thrombocytopenic purpura in adults.
Provan D; Newland A
J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S34-8. PubMed ID: 14668637
[TBL] [Abstract][Full Text] [Related]
37. [Use of vincristine-loaded blood platelets, danazol and gamma globulin in the treatment of patients with idiopathic thrombocytopenic purpura].
Górski J; Czestochowska E; Tymiński W; Kicińska M
Acta Haematol Pol; 1989; 20(1):65-71. PubMed ID: 2618568
[TBL] [Abstract][Full Text] [Related]
38. Management of immune thrombocytopenic purpura in adults.
Stasi R; Provan D
Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
[TBL] [Abstract][Full Text] [Related]
39. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S; Ikehara S
Thromb Haemost; 1992 May; 67(5):563-6. PubMed ID: 1519215
[TBL] [Abstract][Full Text] [Related]
40. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
Maloisel F; Andrès E; Zimmer J; Noel E; Zamfir A; Koumarianou A; Dufour P
Am J Med; 2004 May; 116(9):590-4. PubMed ID: 15093754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
